The global pharmacogenomics market is rapidly evolving, driven by the growing need for personalized medicine, increasing chronic disease burden, and advancements in genetic testing. This market study offers strategic insights into key players, market size, trends, and future opportunities influencing the development and adoption of pharmacogenomics across healthcare sectors.